WO2020236125A3 - An amniotic membrane transplantation system - Google Patents

An amniotic membrane transplantation system Download PDF

Info

Publication number
WO2020236125A3
WO2020236125A3 PCT/TR2020/050568 TR2020050568W WO2020236125A3 WO 2020236125 A3 WO2020236125 A3 WO 2020236125A3 TR 2020050568 W TR2020050568 W TR 2020050568W WO 2020236125 A3 WO2020236125 A3 WO 2020236125A3
Authority
WO
WIPO (PCT)
Prior art keywords
amniotic membrane
membrane transplantation
transplantation system
present
ophthalmology
Prior art date
Application number
PCT/TR2020/050568
Other languages
French (fr)
Other versions
WO2020236125A2 (en
Inventor
Ertugrul CAN
Original Assignee
Ondokuz Mayis Universitesi
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ondokuz Mayis Universitesi filed Critical Ondokuz Mayis Universitesi
Publication of WO2020236125A2 publication Critical patent/WO2020236125A2/en
Publication of WO2020236125A3 publication Critical patent/WO2020236125A3/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/3604Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix characterised by the human or animal origin of the biological material, e.g. hair, fascia, fish scales, silk, shellac, pericardium, pleura, renal tissue, amniotic membrane, parenchymal tissue, fetal tissue, muscle tissue, fat tissue, enamel
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/0095Packages or dispensers for prostheses or other implants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/14Eye parts, e.g. lenses, corneal implants; Implanting instruments specially adapted therefor; Artificial eyes
    • A61F2/145Corneal inlays, onlays, or lenses for refractive correction
    • A61F2/1451Inlays or onlays
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/48Reproductive organs
    • A61K35/50Placenta; Placental stem cells; Amniotic fluid; Amnion; Amniotic stem cells
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/14Eye parts, e.g. lenses, corneal implants; Implanting instruments specially adapted therefor; Artificial eyes
    • A61F2/15Implant having one or more holes, e.g. for nutrient transport, for facilitating handling
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2430/00Materials or treatment for tissue regeneration
    • A61L2430/16Materials or treatment for tissue regeneration for reconstruction of eye parts, e.g. intraocular lens, cornea

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Transplantation (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Medicinal Chemistry (AREA)
  • Vascular Medicine (AREA)
  • Epidemiology (AREA)
  • Cell Biology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Zoology (AREA)
  • Pregnancy & Childbirth (AREA)
  • Molecular Biology (AREA)
  • Reproductive Health (AREA)
  • Biotechnology (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Ophthalmology & Optometry (AREA)
  • Urology & Nephrology (AREA)
  • Botany (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dermatology (AREA)
  • Materials For Medical Uses (AREA)
  • Prostheses (AREA)

Abstract

The present invention relates to an amniotic membrane transplantation system that allows for applying an amniotic membrane to the ocular surface in a sutureless manner in the field of ophthalmology. The present invention is cost-efficient and effective, and may readily be applied to any patient, and ensures that amniotic membrane transplantation procedure may be carried out without the need for operating room conditions.
PCT/TR2020/050568 2019-05-02 2020-07-02 An amniotic membrane transplantation system WO2020236125A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
TR2019/06563 2019-05-02
TR2019/06563A TR201906563A2 (en) 2019-05-02 2019-05-02 An amniotic membrane transplantation system.

Publications (2)

Publication Number Publication Date
WO2020236125A2 WO2020236125A2 (en) 2020-11-26
WO2020236125A3 true WO2020236125A3 (en) 2021-01-14

Family

ID=73459143

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/TR2020/050568 WO2020236125A2 (en) 2019-05-02 2020-07-02 An amniotic membrane transplantation system

Country Status (2)

Country Link
TR (1) TR201906563A2 (en)
WO (1) WO2020236125A2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN117679209A (en) * 2023-12-25 2024-03-12 山东第一医科大学附属眼科医院(山东省眼科医院) Sewing-free biological amniotic membrane for eyes

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040181240A1 (en) * 2002-03-14 2004-09-16 Tseng Scheffer C.G. Amniotic membrane covering for a tissue surface and devices facilitating fastening of membranes
KR20110090242A (en) * 2010-02-03 2011-08-10 주식회사 바이오랜드 Method for preparing contact lens-shaped amniotic dressing
WO2016138025A2 (en) * 2015-02-23 2016-09-01 Tissuetech, Inc. Apparatuses and methods for treating ophthalmic diseases and disorders
TR201723013A2 (en) * 2017-12-29 2018-01-22
TR201904587A2 (en) * 2019-03-27 2019-04-22 Cukurova Ueniversitesi Rektoerluegue SEMBLEFERON RING SET

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040181240A1 (en) * 2002-03-14 2004-09-16 Tseng Scheffer C.G. Amniotic membrane covering for a tissue surface and devices facilitating fastening of membranes
KR20110090242A (en) * 2010-02-03 2011-08-10 주식회사 바이오랜드 Method for preparing contact lens-shaped amniotic dressing
WO2016138025A2 (en) * 2015-02-23 2016-09-01 Tissuetech, Inc. Apparatuses and methods for treating ophthalmic diseases and disorders
TR201723013A2 (en) * 2017-12-29 2018-01-22
TR201904587A2 (en) * 2019-03-27 2019-04-22 Cukurova Ueniversitesi Rektoerluegue SEMBLEFERON RING SET

Also Published As

Publication number Publication date
WO2020236125A2 (en) 2020-11-26
TR201906563A2 (en) 2020-11-23

Similar Documents

Publication Publication Date Title
WO2021150890A3 (en) Devices, systems, and methods for treating ear disorders
EP3600109A4 (en) Systems and methods for ocular laser surgery and therapeutic treatments
AU2018329662A1 (en) Methods, systems, and compositions for maintaining functioning drainage blebs associated with foreign bodies
EP3823568A4 (en) Surgical treatment for glaucoma
EP3846747A4 (en) Ocular device for treating glaucoma and related minimally invasive glaucoma surgery method
EP3829503A4 (en) Full depth laser ophthalmic surgical system, methods of calibrating the surgical system and treatment methods using the same
WO2016187475A8 (en) Multispectral light source
EP3955839A4 (en) Devices, systems and methods for the treatment of abnormal tissue
WO2017200659A3 (en) A method to enhance wound healing using silk-derived protein
EP3829569A4 (en) Spinosyn formulations for treatment of demodex-induced ocular and facial conditions
EP3955937A4 (en) Compounds and methods for the treatment of ocular disorders
EP3906043A4 (en) Methods and compositions for the treatment of fabry disease
WO2020236125A3 (en) An amniotic membrane transplantation system
EP3955926A4 (en) Compounds and methods for the treatment of ocular disorders
WO2020172482A3 (en) Cd80 extracellular domain-fc fusion proteins for treating pd-l1 negative tumors
EP3962424A4 (en) Cloud based system cataract treatment database and algorithm system
WO2020165839A9 (en) Formulations of 4-(7-hydroxy-2-isopropyl-4-oxo-4h-quinazolin-3-yl)-benzonitrile
EP3902525A4 (en) Ophthalmic pharmaceutical compositions and methods for treating ocular surface disease
EP3843642A4 (en) Methods and systems for large spot retinal laser treatment
WO2015048188A3 (en) Modified fibroblast growth factors for the treatment of ocular disorders
EP3989805A4 (en) Devices, systems, and methods for the treatment of clogged glands of the eye
WO2017152129A3 (en) Treatment of glaucoma and/or retinal diseases and formulations useful therefore
WO2020097021A3 (en) Dermal skin protectant and carrier
AU2022300351A1 (en) Transforming growth factor-beta ligand traps for the treatment of disease
WO2017129577A8 (en) Ophthalmic gabapentin for the treatment of corneal ulcers

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 20809650

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 20809650

Country of ref document: EP

Kind code of ref document: A2